SAN CARLOS, Calif.--(BUSINESS WIRE)--Jan. 5, 2006--Natus Medical Incorporated (Nasdaq:BABY) announced that it has completed today its acquisition of Bio-logic Systems Corp. Bio-logic formerly traded ...
SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell ...
The positive preliminary SENTI-202 clinical data was presented on April 27 in a Clinical Trials Oral Minisymposium at the American Association for Cancer Research (AACR) Annual Meeting 2025 in an ...
AGOURA HILLS, Calif.--(BUSINESS WIRE)--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, today announced ...
SAN FRANCISCO (MarketWatch) -- Bio-logic Systems Corp. said Wednesday its shareholders have approved the company's acquisition by Natus Medical Inc. for $8.77 a share, or $68 million. The merger is ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The company plans to work with a local nonprofit ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果